You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 23, June 20, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (182)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Women's Health
 •Papillomavirus, Human
 •Women's Health, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Risks for Incident Human Papillomavirus Infection and Low-Grade Squamous Intraepithelial Lesion Development in Young Females

Anna-Barbara Moscicki, MD; Nancy Hills, MA; Steve Shiboski, PhD; Kim Powell, NP,RN; Naomi Jay, NP,RN; Evelyn Hanson, NP,RN; Susanna Miller, BA; Lisa Clayton; Sepideh Farhat, MS; Jeanette Broering, NP,RN; Teresa Darragh, MD; Joel Palefsky, MD

JAMA. 2001;285:2995-3002.

Context  Low-grade squamous intraepithelial lesions (LSILs) have been described as a benign cytological consequence of active human papillomavirus (HPV) replication. Several studies have reported that certain behavioral and biological risks exist for LSIL, suggesting that HPV alone is not sufficient for the development of LSIL. However, because most of these studies have been cross-sectional, it is not known whether behavioral and biological risks are simply risks for HPV infection itself.

Objective  To prospectively examine risks of incident HPV infection in HPV-negative females and of incident LSIL development in females with HPV infection.

Design  Prospective cohort study conducted between 1990-2000, with a median follow-up of 50 months.

Setting and Participants  Females aged 13 to 21 years who attended 2 family planning clinics in the San Francisco bay area; 496 had prevalent HPV infection and 105 were HPV-negative.

Main Outcome Measure  Incident development of HPV infection and LSIL, analyzed by various demographic, behavioral, and clinical risk factors.

Results  Fifty-four incident HPV infections occurred in the 105 females who were HPV-negative at study entry (median duration of follow-up for those who remained HPV-negative was 26 months). Multivariable analysis showed that risks of HPV included sexual behavior (relative hazard [RH], 10.10; 95% confidence interval [CI], 3.24-31.50 per new partner per month), history of herpes simplex virus (RH, 3.54; 95% CI, 1.37-9.10), and history of vulvar warts (RH, 2.73; 95% CI, 1.27-5.87). Current use of oral contraceptives had a significantly protective effect (RH, 0.49; 95% CI, 0.28-0.86). Among the 496 individuals who were HPV-positive at baseline or in follow-up, there were 109 incident cases of LSIL during the follow-up interval, with a median follow-up time of 60 months for those who never developed LSIL. Human papillomavirus infection was the most significant risk factor for development of LSIL. The multivariable model showed the following risks for LSIL: HPV infection for less than 1 year (RH, 7.40; 95% CI, 4.74-11.57); HPV infection for 1 to 2 years (RH, 10.27; 95% CI, 5.64-18.69); HPV infection for 2 to 3 years (RH, 6.11; 95% CI, 1.86-20.06); and daily cigarette smoking (RH, 1.67; 95% CI, 1.12-2.48).

Conclusion  Our results indicate distinct risks for HPV and LSIL. In addition, most women with HPV infection in our study did not develop LSIL within a median follow-up period of 60 months. These findings underscore the hypothesis that certain biological risks thought to be associated with LSIL are, in fact, risks for acquisition of HPV. Cigarette smoking was a risk specific to LSIL, supporting the role of tobacco in neoplastic development.


Author Affiliations: Departments of Pediatrics (Dr Moscicki and Mss Hills, Powell, Jay, Hanson, Miller, Clayton, Farhat, and Broering), Epidemiology and Biostatistics (Dr Shiboski), Anatomic Pathology (Dr Darragh), and Stomatology (Dr Palefsky), University of California, San Francisco.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTER

Role of Immune Function in Human Papillomavirus Infection
Janet Buchanan, Nancy S. Nieland-Fisher, Anna-Barbara Moscicki, Nancy K. Hills, Terry Darragh, and Steve Shiboski
JAMA. 2001;286(10):1173-1174.
EXTRACT | FULL TEXT  

RELATED ARTICLE

June 20, 2001
JAMA. 2001;285(23):3035-3036.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Case 10-2009 -- A 23-Year-Old Woman with an Abnormal Papanicolaou Smear
Goldstein et al.
NEJM 2009;360:1337-1344.
FULL TEXT  

Persistence of an Incident Human Papillomavirus Infection and Timing of Cervical Lesions in Previously Unexposed Young Women
Trottier et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:854-862.
ABSTRACT | FULL TEXT  

Human Papillomavirus Cofactors by Disease Progression and Human Papillomavirus Types in the Study to Understand Cervical Cancer Early Endpoints and Determinants
Wang et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:113-120.
ABSTRACT | FULL TEXT  

Prevalence, Acquisition, and Clearance of Cervical Human Papillomavirus Infection among Women with Normal Cytology: Hawaii Human Papillomavirus Cohort Study
Goodman et al.
Cancer Res. 2008;68:8813-8824.
ABSTRACT | FULL TEXT  

The Pediatrician's Role in Preventing Cervical Cancer
Blatter and Monk
CLIN PEDIATR 2008;47:627-638.
 

Prevalence of Genital Human Papilloma Virus Infection and Genotypes among Young Women in Sicily, South Italy
Ammatuna et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2002-2006.
ABSTRACT | FULL TEXT  

Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis
Koshiol et al.
Am J Epidemiol 2008;168:123-137.
ABSTRACT | FULL TEXT  

Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys
Vaccarella et al.
Int J Epidemiol 2008;37:536-546.
ABSTRACT | FULL TEXT  

Frequently asked questions about genital warts in the genitourinary medicine clinic: an update and review of recent literature
Goon and Sonnex
Sex. Transm. Infect. 2008;84:3-7.
ABSTRACT | FULL TEXT  

Determination of Cytokine Protein Levels in Cervical Mucus Samples from Young Women by a Multiplex Immunoassay Method and Assessment of Correlates
Lieberman et al.
CVI 2008;15:49-54.
ABSTRACT | FULL TEXT  

Characterization and Experimental Transmission of an Oncogenic Papillomavirus in Female Macaques
Wood et al.
J. Virol. 2007;81:6339-6345.
ABSTRACT | FULL TEXT  

Reproductive Health of Adolescent Girls Perinatally Infected With HIV
Brogly et al.
Am. J. Public Health 2007;97:1047-1052.
ABSTRACT | FULL TEXT  

Betapapillomaviruses frequently persist in the skin of healthy individuals
de Koning et al.
J. Gen. Virol. 2007;88:1489-1495.
ABSTRACT | FULL TEXT  

Modeling Human Papillomavirus Vaccine Effectiveness: Quantifying the Impact of Parameter Uncertainty
Van de Velde et al.
Am J Epidemiol 2007;165:762-775.
ABSTRACT | FULL TEXT  

What Do Women in the U.S. Know about Human Papillomavirus and Cervical Cancer?
Tiro et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:288-294.
ABSTRACT | FULL TEXT  

American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors
Saslow et al.
CA Cancer J Clin 2007;57:7-28.
ABSTRACT | FULL TEXT  

Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys.
Vaccarella et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:2148-2153.
ABSTRACT | FULL TEXT  

The Absolute Risk of Cervical Abnormalities in High-risk Human Papillomavirus-Positive, Cytologically Normal Women Over a 10-Year Period
Kjaer et al.
Cancer Res. 2006;66:10630-10636.
ABSTRACT | FULL TEXT  

Condom use and the risk of genital human papillomavirus infection in young women.
Winer et al.
NEJM 2006;354:2645-2654.
ABSTRACT | FULL TEXT  

Smokers at higher risk for undetected antibody for oncogenic human papillomavirus type 16 infection.
Wiley et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:915-920.
ABSTRACT | FULL TEXT  

Modeling the Sexual Transmissibility of Human Papillomavirus Infection using Stochastic Computer Simulation and Empirical Data from a Cohort Study of Young Women in Montreal, Canada
Burchell et al.
Am J Epidemiol 2006;163:534-543.
ABSTRACT | FULL TEXT  

Epidemiology and Natural History of Genital Human Papillomavirus Infection
Weaver
JAOA: Journal of the American Osteopathic Association 2006;106:S2-S8.
ABSTRACT | FULL TEXT  

Association of Condom Use, Sexual Behaviors, and Sexually Transmitted Infections With the Duration of Genital Human Papillomavirus Infection Among Adolescent Women
Shew et al.
Arch Pediatr Adolesc Med 2006;160:151-156.
ABSTRACT | FULL TEXT  

Incident High-Grade Squamous Intraepithelial Lesions in Senegalese Women With and Without Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2
Hawes et al.
JNCI J Natl Cancer Inst 2006;98:100-109.
ABSTRACT | FULL TEXT  

Association of Chlamydia trachomatis with Persistence of High-Risk Types of Human Papillomavirus in a Cohort of Female Adolescents
Samoff et al.
Am J Epidemiol 2005;162:668-675.
ABSTRACT | FULL TEXT  

Management of low-grade cervical lesions in young women
Lau and Franco
CMAJ 2005;173:771-774.
FULL TEXT  

Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences
De la Cruz-Hernandez et al.
J. Gen. Virol. 2005;86:2459-2468.
ABSTRACT | FULL TEXT  

Spontaneous Regression of High-Grade Cervical Dysplasia: Effects of Human Papillomavirus Type and HLA Phenotype
Trimble et al.
Clin. Cancer Res. 2005;11:4717-4723.
ABSTRACT | FULL TEXT  

Sexual behaviour and high risk human papillomavirus infections in Japanese women
Sasagawa et al.
Sex. Transm. Infect. 2005;81:280-282.
FULL TEXT  

Modifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students
Richardson et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:1149-1156.
ABSTRACT | FULL TEXT  

Semiquantitative Human Papillomavirus Type 16 Viral Load and the Prospective Risk of Cervical Precancer and Cancer
Castle et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:1311-1314.
ABSTRACT | FULL TEXT  

Detection of Human Papillomavirus Infection of the Cervix in Very Elderly Women Using PCR
Takubo et al.
Clin. Cancer Res. 2005;11:2919-2923.
ABSTRACT | FULL TEXT  

Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain
del Amo et al.
Sex. Transm. Infect. 2005;81:79-84.
ABSTRACT | FULL TEXT  

HPV-Associated Pap Smear Changes Usually Regress in Young Women
Moyer
AAP Grand Rounds 2005;13:16-17.
FULL TEXT  

Folate Is Associated with the Natural History of High-Risk Human Papillomaviruses
Piyathilake et al.
Cancer Res. 2004;64:8788-8793.
ABSTRACT | FULL TEXT  

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Goldie et al.
JNCI J Natl Cancer Inst 2004;96:604-615.
ABSTRACT | FULL TEXT  

Depressed Type 1 Cytokine Synthesis by Superantigen-Activated CD4+ T Cells of Women with Human Papillomavirus-Related High-Grade Squamous Intraepithelial Lesions
Lee et al.
CVI 2004;11:239-244.
ABSTRACT | FULL TEXT  

Acquisition of High-Risk Human Papillomavirus Infections and Pap Smear Abnormalities among Women in the New Independent States of the Former Soviet Union
Syrjanen et al.
J. Clin. Microbiol. 2004;42:505-511.
ABSTRACT | FULL TEXT  

Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future?
Mandic and Vujkov
Ann Oncol 2004;15:197-200.
ABSTRACT | FULL TEXT  

Modeling the Time Dependence of the Association between Human Papillomavirus Infection and Cervical Cancer Precursor Lesions
Schlecht et al.
Am J Epidemiol 2003;158:878-886.
ABSTRACT | FULL TEXT  

Incidence of Anal Cytological Abnormalities in a Cohort of Human Immunodeficiency Virus-infected Women
Durante et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:638-642.
ABSTRACT | FULL TEXT  

The Natural History of Type-specific Human Papillomavirus Infections in Female University Students
Richardson et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:485-490.
ABSTRACT | FULL TEXT  

Human papillomavirus type 6 virus-like particles present overlapping yet distinct conformational epitopes
Wang et al.
J. Gen. Virol. 2003;84:1493-1497.
ABSTRACT | FULL TEXT  

Chapter 2: Natural History of Anogenital Human Papillomavirus Infection and Neoplasia
Schiffman and Kjaer
J Natl Cancer Inst Monogr 2003;2003:14-19.
ABSTRACT | FULL TEXT  

Chapter 3: Cofactors in Human Papillomavirus Carcinogenesis--Role of Parity, Oral Contraceptives, and Tobacco Smoking
Castellsague and Munoz
J Natl Cancer Inst Monogr 2003;2003:20-28.
ABSTRACT | FULL TEXT  

Chapter 18: Statistical Issues in the Design and Analysis of Studies of Human Papillomavirus and Cervical Neoplasia
Wacholder
J Natl Cancer Inst Monogr 2003;2003:125-130.
ABSTRACT | FULL TEXT  

Epidemiologic Studies of a Necessary Causal Risk Factor: Human Papillomavirus Infection and Cervical Neoplasia
Schiffman and Castle
JNCI J Natl Cancer Inst 2003;95:E2-E2.
FULL TEXT  

Incidence, clearance and predictors of human papillomavirus infection in women
Sellors et al.
CMAJ 2003;168:421-425.
ABSTRACT | FULL TEXT  

Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University Students
Winer et al.
Am J Epidemiol 2003;157:218-226.
ABSTRACT | FULL TEXT  

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky et al.
NEJM 2002;347:1645-1651.
ABSTRACT | FULL TEXT  

Time Course of Humoral and Cell-Mediated Immune Responses to Human Papillomavirus Type 16 in Infected Women
Nakagawa et al.
CVI 2002;9:877-882.
ABSTRACT | FULL TEXT  

Human Papillomavirus Persistence and Nutrients Involved in the Methylation Pathway among a Cohort of Young Women
Sedjo et al.
Cancer Epidemiol. Biomarkers Prev. 2002;11:353-359.
ABSTRACT | FULL TEXT  

Cervical intraepithelial neoplasia in women presenting with external genital warts
Howard et al.
CMAJ 2002;166:598-599.
FULL TEXT  

Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia
Schlecht et al.
JAMA 2001;286:3106-3114.
ABSTRACT | FULL TEXT  

Role of Immune Function in Human Papillomavirus Infection
Buchanan et al.
JAMA 2001;286:1173-1174.
FULL TEXT  

Why Do Only Some Women with HPV Infection Develop LSILs?
JWatch Women's Health 2001;2001:12-12.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.